Results 71 to 80 of about 9,355 (191)

Development of Multidisciplinary Consensus‐Informed Guidance for the Management of Paediatric Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Clinicians From Australasian Tertiary Referral Hospitals

open access: yesJournal of Paediatrics and Child Health, EarlyView.
ABSTRACT Background Paediatric Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare, severe mucocutaneous reaction requiring coordinated multidisciplinary care. Existing guidelines provide evidence‐based recommendations, but implementation across tertiary paediatric hospitals requires practical consensus on local resources.
Patrick David Mahar   +32 more
wiley   +1 more source

Systemic Disease Associations of Oral Lichenoid Disease: A Retrospective Case–Control Study

open access: yesOral Diseases, EarlyView.
ABSTRACT Objective To analyze the association between oral lichen planus (OLP), oral lichenoid lesions (OLL), and other comorbidities. Material and Methods A case–control study of 205 OLP, 96 OLL patients, and 301 age‐ and sex‐matched controls from Kuopio University Hospital was performed.
Mari Vehviläinen   +3 more
wiley   +1 more source

Coagulation activation in autoimmune bullous diseases

open access: yesClinical and Experimental Immunology, 2009
SummaryThe main autoimmune blistering skin disorders are pemphigus vulgaris (PV) and bullous pemphigoid (BP). They differ in the inflammatory infiltrate, which is more intense in BP. Inflammation is known to activate coagulation in several disorders. Local and systemic activation of coagulation was evaluated in BP and PV.
A.V. Marzano   +5 more
openaire   +4 more sources

Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset. [PDF]

open access: yesFront Immunol, 2022
Russo R   +4 more
europepmc   +1 more source

Dupilumab‐Induced Psoriasis in a Patient with Bullous Pemphigoid

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Nina Matthes   +6 more
wiley   +1 more source

Study of Clinical Characteristics of Desquamative Gingivitis in 60 Patients in the North of Spain

open access: yesInternational Journal of Dental Hygiene, Volume 24, Issue 3, Page 404-410, August 2026.
ABSTRACT Objectives The aim of this study is to know the clinical characteristics of desquamative gingivitis (DG) in a Spanish population in order to make an early diagnosis of this sign and, therefore, the underlying systemic disease. Methods A cross‐sectional study was conducted.
Valeria Sanmartín‐Barragáns   +7 more
wiley   +1 more source

Vitamin D in autoimmune bullous disease

open access: yesActa Biochimica Polonica, 2020
Numerous epidemiological studies have suggested a link between vitamin D deficiency and the development of various autoimmune diseases, including diabetes mellitus type 1, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis or systemic lupus erythematosus.
openaire   +3 more sources

Mucous Membrane Pemphigoid After Anti‐PD‐1 Therapy: Risk‐Stratified Management and Treatment Outcomes

open access: yesInternational Journal of Dermatology, Volume 65, Issue 7, Page 1376-1382, July 2026.
ABSTRACT Mucous membrane pemphigoid (MMP) following anti‐programmed cell death‐1 (PD‐1) therapy is rare but increasingly reported. Management of high‐ and low‐risk MMP in this setting and the potential oncologic trade‐offs remain poorly defined. We performed a narrative synthesis of all published cases of anti‐PD‐1‐associated MMP, following MEDLINE ...
Serena Dienes   +2 more
wiley   +1 more source

Ultrastructural immunocytochemistry of autoimmune bullous diseases

open access: yesAustralasian Journal of Dermatology, 2002
SUMMARYAdvanced immunopathological assays have been developed to elucidate the pathophysiology and provide more precise nosological definitions of the immunobullous diseases. Forty‐seven patients suffering from autoimmune bullous diseases (intra‐ or subepidermal) were studied by immunoelectron microscopy (direct and indirect).
Karpouzis, A.   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy